SPONSORED FUNDING NSU’s total sponsored funding demonstrates an upward trend over the last decade. At the close of FY 2021, the university’s sponsored funding totaled $139.9 million, which represents a 10% increase since FY 2020, and a 70% increase since FY 2012. Funding to support research represents 47% of this total with teaching /training and service comprising the balance. The university is receiving sponsored funding from 100 different funding entities, with the largest amount, 60%, coming directly from the federal government; state and local government represented 17% and 15% of total funding, respectively. Funding from other non-profit corporations, foundations, and other universities round out the sponsored funding portfolio. In FY 2021, there were 214 proposals processed through the NSU Office of Sponsored Programs. LEADING THERAPEUTIC AREAS IN CLINICAL RESEARCH Dentifrices and Implants College of Dental Medicine Contact Lens Assessment in Youth, Dry Eye, and Retina Imaging College of Optometry Nutraceutical Intervention for Oxidative Stress College of Pharmacy Nutraceutical Intervention NSU’s Pediatric Dental Clinic NSU TECHNOLOGIES NSU is able to recognize high-potential technologies, assess their technical and commercial feasibility, secure patent protection, and conduct transactions with commercialization partners for the ultimate benefit of the public. NSU technologies that are ready for commercialization include • automated landing gear systems for trailers • a computational model to predict drug treatment courses • a portfolio of small-molecule cancer therapeutics • comprehensive genetic data for complex diseases • diagnostic for genetic mutations • digital authentication/auditing of pharmacy programs • digital career guidance system for minorities in a health care profession • electronic coordination of health care • image compression and encryption • modified natural killer cells for immunotherapy • novel method for diagnosing complex immune diseases • novel method for modulating oncolytic viruses • novel therapy for skin cancer • novel treatment for breast cancer • novel treatment for lung diseases • novel vaccine for HIV • system for reducing adverse health events in assisted living facilities • the delivery of personalized health care information • therapies for treatment of heart failure
RkJQdWJsaXNoZXIy NDE4MDg=